Patents by Inventor Alexander Moore
Alexander Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11984655Abstract: A radome structure may include an inner tuning layer component and a laminate component overlying the inner tuning layer component. The inner tuning layer component may include a thermoset foam or a thermoplastic foam. The laminate component may include a first fiber reinforced dielectric layer, a second fiber reinforced dielectric layer overlying the first fiber reinforced dielectric layer, and a third fiber reinforced dielectric layer overlying the second fiber reinforced dielectric layer. The first fiber reinforced dielectric layer may include a first low dielectric constant material. The second fiber reinforced dielectric layer may include a first high dielectric constant material. The third fiber reinforced dielectric layer may include a second low dielectric constant material.Type: GrantFiled: December 12, 2019Date of Patent: May 14, 2024Assignee: SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATIONInventors: Levi Moore, Eric R. Oswald, David Winfield Stresing, Steven Kleine, Alexander Kieckhafer, Megan Utter, Sarah E. Taggart
-
Patent number: 11977919Abstract: Techniques for secure and efficient interfacing with a cloud computing service are described. In an embodiment, a cloud computing management service is programmed or configured to communicate with a cloud computing service. The cloud computing management service can be accessed by software engineers that are looking to deploy a software instance to a computing device of the cloud computing service. Thus, the cloud computing management service acts as an intermediary layer in front of the cloud computing service. In an embodiment, the cloud computing management service may store one or more frequently-used system parameters for deployment of software instances. The parameters conform to company's security protocols, compliance protocols, and/or other standards.Type: GrantFiled: June 4, 2021Date of Patent: May 7, 2024Assignee: Palantir Technologies Inc.Inventors: Daniel Paquette, Huw Pryce, Alexander Feldman, Ryan Zheng, Daniel Walker, Cody Moore, Patricio Velez, Gustav Brodman, Jakub Kozlowski, Eric Wong, Steven Capetta, Charles Post, Rick White
-
Patent number: 11960982Abstract: A system and method may partition and/or execute a NN, by, for a graph including nodes and hyper edges, each node representing a data item in the NN and each hyper edge representing an operation in the NN, identifying a deep tensor column comprising a subset of the nodes and a subset of the hyper edges, such that the operations in the deep tensor column, when executed, use only data which fits within a preselected cache.Type: GrantFiled: October 21, 2022Date of Patent: April 16, 2024Assignee: NEURALMAGIC, INC.Inventors: Alexander Matveev, Nir Shavit, Govind Ramnarayan, Tyler Michael Smith, Sage Moore
-
Patent number: 11954649Abstract: A system is provided which that allows users of electronic communication systems and/or calendar systems the ability to suggest meetings to users of different electronic communication systems and/or calendar systems via electronic messages. The system may provide users with the ability to share calendar availability with users of other electronic communication systems and/or calendar systems via electronic message. One aspect of the disclosed system is the fact that users can share interactive calendar information, and propose and confirm tentative meetings and events, with users of different electronic communications and/or calendar systems. Additionally, calendar information that is shared with others may be dynamically updated even after the electronic messages have been sent.Type: GrantFiled: April 27, 2022Date of Patent: April 9, 2024Assignee: Baydin, Inc.Inventors: Alexander Moore, Michael Chin, Aye Moah, Alexey Komissarouk
-
Publication number: 20240102024Abstract: The present disclosure provides host cells, e.g., bacterial cells, that comprise a methionine decarboxylase enzyme for the treatment of diseases and disorders associated with methionine metabolism in a subject. The disclosure further provides pharmaceutical compositions and methods of treating disorders associated with methionine metabolism, such as homocystinuria.Type: ApplicationFiled: November 30, 2023Publication date: March 28, 2024Inventors: Dylan Alexander Carlin, Vincent M. Isabella, Jonathan McMurry, Theodore Carlton Moore, III, Mylene Perreault, Nathan Schmidt, Mark Simon
-
Publication number: 20240089185Abstract: Example embodiments involve a metrics collection system for collecting software usage metrics from one or more client devices at deployments. A computer, such as a server configured to execute the metrics collection system, collects software usage metrics (e.g., as a metrics submission from a client device) of the software product at the deployment, identifies a metrics type of the software usage metrics collected, assigns the software usage metrics to a metrics category, and calculates and updates a metrics score of the metrics category, based on the software usage metrics collected.Type: ApplicationFiled: November 21, 2023Publication date: March 14, 2024Applicant: Palantir Technologies Inc.Inventors: Cody Moore, Yiwei Gao, Andrew Colombi, David Karesh, William Ward, Alexander Ince-Cushman, Mohammad Bukhari, Daniel Kozlowski, Jason Richardson
-
Publication number: 20240073220Abstract: Malicious homoglyphic domain name (MHDN) generation and associated cyber security applications are described. MHDN generation may be performed by, for example, generating, based on training data, a set of operations for use in generating the one or more potential MHDNs, wherein each operation of the set of operations may be configured to modify a base domain name according to a respective homoglyphic characteristic. The set of operations may be used to generate one or more candidate MHDN mutators. The candidate MHDN mutators may be tested for fitness values corresponding to respective likelihoods of generating an MHDN and the candidate MHDN mutators may be applied to one or more base domain names to generate potential MHDNs.Type: ApplicationFiled: October 31, 2023Publication date: February 29, 2024Inventors: Vincent Mutolo, Alexander Chinchilli, Sean Moore, Matthew Sparrow, Connor Tess
-
Publication number: 20240066905Abstract: A micro-transfer structure comprises a stamp comprising a rigid support, only a single contiguous bulk layer disposed on the rigid support, and posts disposed on the bulk layer. Components are adhered to (e.g., disposed in contact with) some but not all of the posts. The posts can be substantially identical and disposed in a regular array on the bulk layer. Each component is adhered to (e.g., in contact with) two or more posts. Components can be disposed on a source wafer entirely over sacrificial portions of a sacrificial layer on or in the source wafer and attached to anchors disposed between sacrificial portions with a tether.Type: ApplicationFiled: November 7, 2023Publication date: February 29, 2024Inventors: Tanya Yvette Moore, David Gomez, Christopher Andrew Bower, Matthew Alexander Meitl, Salvatore Bonafede
-
Publication number: 20240071257Abstract: A surgeon training apparatus includes a cassette, which includes biological tissue repurposed into a form consistent with the anatomical configuration of abdominal hernias, affixed into an anatomically correct silicon framework which replicates the abdominal anatomy. The framework positions the cassette in an anatomically correct position within the abdominal cavity, enabling surgeons to train using a properly positioned representation of the target anatomy, thus requiring the surgeon to properly use surgical tools to correct the pathologic condition caused by the hernia. The cassette is formed by applying biologic tissue to a specially designed “plate,” which affixes the tissue block into the anatomic framework, and is adapted for connection to a grounding device so the surgeon can use cautery during the simulated hernia repair.Type: ApplicationFiled: November 7, 2023Publication date: February 29, 2024Inventors: JOHN ALEXANDER, W. ANDREW GRUBBS, KAITY YU EMERSON, MORGAN DOMINICE MOORE, MEGAN HARRISION DEW, SAMUEL DAVID DREW
-
Patent number: 11914957Abstract: Systems and methods for dynamically assessing and displaying quality features of electronic messages, while composed on client devices, can include one or more processors monitoring the process of composing the electronic message. The one or more processors can retrieve, upon detecting a pause event, data associated with the composed electronic message from a message composing container, and determine a plurality of feature values for a plurality of features of the electronic message based on the retrieved data. The one or more processors can determine, based on the plurality of feature values, a likelihood of receiving a response from a receiving entity once the electronic message is sent to that receiving entity. The one or more processors can provide an indication of the determined likelihood of receiving a response and indications of the plurality of determined feature values for display in association with a message composing window displaying the text received.Type: GrantFiled: June 17, 2022Date of Patent: February 27, 2024Assignee: Baydin, Inc.Inventors: Aye Moah, Alexander Moore, Michael Chin
-
Publication number: 20240042036Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: September 29, 2023Publication date: February 8, 2024Applicant: Fennec Pharmaceuticals IncInventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230201350Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: February 20, 2023Publication date: June 29, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230201349Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: February 20, 2023Publication date: June 29, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230201351Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: February 20, 2023Publication date: June 29, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230158145Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: November 22, 2022Publication date: May 25, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Patent number: 11617793Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: GrantFiled: July 22, 2022Date of Patent: April 4, 2023Assignee: Fennec Pharmaceuticals, Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher Mckinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230094842Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: November 22, 2022Publication date: March 30, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230094886Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.Type: ApplicationFiled: November 22, 2022Publication date: March 30, 2023Applicant: Fennec Pharmaceuticals Inc.Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Chirstopher McKinnon Lee, Daniel Logan Kirschner
-
Publication number: 20230081134Abstract: Systems and methods for dynamically assessing and displaying quality features of electronic messages, while composed on client devices, can include one or more processors monitoring the process of composing the electronic message. The one or more processors can retrieve, upon detecting a pause event, data associated with the composed electronic message from a message composing container, and determine a plurality of feature values for a plurality of features of the electronic message based on the retrieved data. The one or more processors can determine, based on the plurality of feature values, a likelihood of receiving a response from a receiving entity once the electronic message is sent to that receiving entity. The one or more processors can provide an indication of the determined likelihood of receiving a response and indications of the plurality of determined feature values for display in association with a message composing window displaying the text received.Type: ApplicationFiled: June 17, 2022Publication date: March 16, 2023Applicant: Baydin, Inc.Inventors: Aye Moah, Alexander Moore, Michael Chin
-
Publication number: 20230031878Abstract: A system is provided which that allows users of electronic communication systems and/or calendar systems the ability to suggest meetings to users of different electronic communication systems and/or calendar systems via electronic messages. The system may provide users with the ability to share calendar availability with users of other electronic communication systems and/or calendar systems via electronic message. One aspect of the disclosed system is the fact that users can share interactive calendar information, and propose and confirm tentative meetings and events, with users of different electronic communications and/or calendar systems. Additionally, calendar information that is shared with others may be dynamically updated even after the electronic messages have been sent.Type: ApplicationFiled: April 27, 2022Publication date: February 2, 2023Applicant: Baydin, Inc.Inventors: Alexander Moore, Michael CHIN, Aye Moah, Alexey Komissarouk